Cochlear Ltd Pledges $10 million to Johns Hopkins to Fund Hearing Loss and Public Health Research

CENTENNIAL, COLORADO — Cochlear Limited announced that it will be pledging a gift of $10 million to the Johns Hopkins Bloomberg School of Public Health to establish the Cochlear Center for Hearing and Public Health. According to the announcement, the new Center will be led by Dr. Frank Lin and will be the first of…

Read More
frequency therapeutics hearing loss drug development

Frequency Therapeutics Announces Successful Completion of First-in-Human Study of FX-322, Company’s Leading Candidate for Hearing Restoration

WOBURN, MASSACHUSSETTS – Biotech startup, Frequency Therapeutics, announced late last month the successful completion of a first-in-human study of the company’s investigative compound FX-322, the company’s lead Progenitor Cell Activation (PCA) candidate for hearing restoration. The preliminary results were recently presented at a lecture last month at the US-Japan Symposium on Drug Delivery. According to…

Read More
akouos genetic hearing loss restore

Boston-Based Biotech, Akouos, Nets $7.5M Investment to “Restore and Preserve Hearing”

BOSTON, MASSACHUSETTS — Biotechnology startup, Akouos, announced that it has raised $7.5 million in seed funding. The company, which was spun out of the Harvard Innovation Labs, is developing novel therapies and delivery systems to prevent hearing loss and restore hearing in genetically defined populations. New Enterprise Associates (NEA), who led the seed funding along…

Read More

Using Laser Light to Restore Sound: Researchers Develop Optical Cochlear Implant

European engineers from Germany, Switzerland, and Austria have invented a new type of cochlear implant. Unlike traditional cochlear implants that stimulate auditory nerves with electrical fields, the prototype device uses laser pulses to trigger auditory signals from hair cells in the inner ear. The benefit, say the researchers, is a much more focused device that…

Read More
hearing loss brain aging research umd

University of Maryland Receives $8 Million Federal Grant for Hearing Loss Research

COLLEGE PARK, MARYLAND — Researchers at the University of Maryland, using an $8 million grant from The National Institute on Aging, are collaborating to investigate hearing loss and brain function. The five-year grant will fund three such projects at the university, which researchers hope to begin as soon as possible. It is estimated that there…

Read More
stem cells cochlear inner ear

Study Shows Potential Promise and Peril in Reversing Cochlear Hearing Loss

Hearing loss is a serious global morbidity that affects 360 million people worldwide, according to the World Health Organization. At a basic level, hearing loss of adult onset can be a source of social isolation and even depression for individuals coping with its ill-effects. Even more consequential, children with hearing loss are at risk of…

Read More
hidden hearing loss noise

New Study Finds No Relationship Between Common Recreational Noise Exposure, “Hidden Hearing Loss”

DALLAS, TEXAS — According to a recently published study, no relationship has been found between common recreational noise exposure and so-called “hidden hearing loss”. The study, conducted by researchers at the University of Texas (UT) Dallas, was published last month in Frontiers in Neuroscience. Previously, researchers have proposed that recreational noise exposure may result in…

Read More
hearing loss cisplatin drug sens-401

Study finds Sensorion’s Investigative Drug Prevented Cisplatin-Induced Hearing Loss By More Than 50 Percent

MONTPELLIER, FRANCE — French biotech firm, Sensorion, announced the upcoming publication this week in the Journal of Otology & Neurotology of a new study showing oral clinical-stage SENS-401 (the company’s investigative drug) significantly prevented cisplatin-induced hearing loss in preclinical models. Cisplatin, a commonly-used chemotherapy agent to treat various forms of cancer, causes significant levels of…

Read More

Australian Researchers Develop New Brain Mapping Method to Assess Hearing Status in Infants

MELBOURNE, AUSTRALIA — Researchers at the BABILab, part of the Bionics Institute in Melbourne, are mapping the brains of babies to determine whether or not hearing aids or cochlear implants are helping to develop language centers in the brain. Sensors placed in skullcaps worn by babies engaged in auditory and language tasks provide a unique…

Read More
auris medical hearing loss am-111

Auris Medical Completes Enrollment of Phase 3 Trial of AM-111 Drug, to Treat Sudden Sensorineural Hearing Loss

ZUG, SWITZERLAND — Biopharmaceutical company Auris Medical Holdings announced today that it  has completed patient enrollment in the Phase 3 trial of its novel AM-111 drug, to treat idiopathic sudden sensorineural hearing loss (ISSNHL)–also known as sudden deafness. Results from the trial are anticipated to be available in the fall of this year.   HEALOS Trial…

Read More